NO994138L - Rensing av von Willebrand-faktor ved kationebytterkromatografi - Google Patents

Rensing av von Willebrand-faktor ved kationebytterkromatografi

Info

Publication number
NO994138L
NO994138L NO994138A NO994138A NO994138L NO 994138 L NO994138 L NO 994138L NO 994138 A NO994138 A NO 994138A NO 994138 A NO994138 A NO 994138A NO 994138 L NO994138 L NO 994138L
Authority
NO
Norway
Prior art keywords
purification
cation exchange
exchange chromatography
von willebrand
willebrand factor
Prior art date
Application number
NO994138A
Other languages
English (en)
Other versions
NO324659B1 (no
NO994138D0 (no
Inventor
Bernhard Fischer
Iyvind L Schoenberger
Artur Mitterer
Christian Fiedler
Friedrich Dorner
Johann Eibl
Original Assignee
Baxter Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Ag filed Critical Baxter Ag
Publication of NO994138L publication Critical patent/NO994138L/no
Publication of NO994138D0 publication Critical patent/NO994138D0/no
Publication of NO324659B1 publication Critical patent/NO324659B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Treatment Of Water By Ion Exchange (AREA)
  • Confectionery (AREA)
NO19994138A 1997-02-27 1999-08-26 Utvinning av von Willebrand-faktor ved kationebytterkromatografi samt preparat inneholdende slik faktor og anvendelse derav. NO324659B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0033797A AT405403B (de) 1997-02-27 1997-02-27 Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie
PCT/AT1998/000034 WO1998038219A1 (de) 1997-02-27 1998-02-18 Reinigung von von willebrand-faktor durch kationenaustauscherchromatographie

Publications (3)

Publication Number Publication Date
NO994138L true NO994138L (no) 1999-08-26
NO994138D0 NO994138D0 (no) 1999-08-26
NO324659B1 NO324659B1 (no) 2007-11-26

Family

ID=3487918

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19994138A NO324659B1 (no) 1997-02-27 1999-08-26 Utvinning av von Willebrand-faktor ved kationebytterkromatografi samt preparat inneholdende slik faktor og anvendelse derav.

Country Status (11)

Country Link
US (1) US6465624B1 (no)
EP (1) EP1005492B1 (no)
JP (1) JP4250770B2 (no)
AT (2) AT405403B (no)
AU (1) AU737986B2 (no)
CA (1) CA2282843C (no)
DE (1) DE59813967D1 (no)
DK (1) DK1005492T3 (no)
ES (1) ES2285754T3 (no)
NO (1) NO324659B1 (no)
WO (1) WO1998038219A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT406373B (de) 1997-02-27 2000-04-25 Immuno Ag Verfahren zur reinigung von faktor viii/vwf-komplex mittels kationenaustauscherchromatographie
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
AT408443B (de) * 1998-02-27 2001-11-26 Immuno Ag Verfahren zur gewinnung von gereinigtem faktor viii:c/vwf-komplex
US6605222B1 (en) * 1998-05-20 2003-08-12 Baxter Aktiengesellschaft Method for producing a factor VIII/von Willebrand factor complex
FR2874216B1 (fr) * 2004-08-16 2006-11-03 Lab Francais Du Fractionnement Procede de preparation d'un concentre de facteur von willebrand (fvw) par voie chromatographique et concentre de fvw susceptible d'etre ainsi obtenu
US7566701B2 (en) * 2004-09-07 2009-07-28 Archemix Corp. Aptamers to von Willebrand Factor and their use as thrombotic disease therapeutics
BRPI0514984A (pt) 2004-09-07 2008-07-01 Archemix Corp aptámeros para o fator de von willebrand e sua utilização como terapêuticos para doença trombótica
WO2006029258A2 (en) * 2004-09-07 2006-03-16 Archemix Corp. Aptamer medicinal chemistry
DE102004044429B4 (de) * 2004-09-14 2009-04-30 Biotest Ag Verfahren zur Herstellung einer Zusammensetzung enthaltend von Willebrand Faktor
DE102004044419B4 (de) 2004-09-14 2010-04-15 Biotest Ag Verfahren zur Aufreinigung eines von Willebrand Faktors mittels Hydroxylapatit-Durchlaufchromatographie
ES2434035T3 (es) 2004-12-27 2013-12-13 Baxter International Inc. Conjugados de polímero-factor von Willebrand
CA2647314A1 (en) 2006-03-31 2007-11-08 Baxter International Inc. Pegylated factor viii
WO2008150495A2 (en) * 2007-06-01 2008-12-11 Archemix Corp. Vwf aptamer formulations and methods for use
CN105816858A (zh) 2007-12-28 2016-08-03 巴克斯特国际公司 重组vwf配方
US11197916B2 (en) 2007-12-28 2021-12-14 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
AU2009307648C1 (en) 2008-10-21 2016-12-08 Takeda Pharmaceutical Company Limited Lyophilized recombinant VWF formulations
BR112012003802B1 (pt) 2009-08-20 2022-10-25 Takeda Pharmaceutical Company Limited Método para remover um vírus sem envelope lipídico de uma solução
WO2012082933A1 (en) 2010-12-15 2012-06-21 Baxter International, Inc. Eluate collection using conductivity gradient
KR20190041032A (ko) * 2011-06-10 2019-04-19 박스알타 인코퍼레이티드 재조합 vwf의 투여에 의한 응고 질환의 치료
WO2015188224A1 (en) 2014-06-13 2015-12-17 Csl Limited Improved production of recombinant von willebrand factor in a bioreactor
JP7307047B2 (ja) 2017-07-07 2023-07-11 武田薬品工業株式会社 組換えｖｗｆの投与による重度のフォンヴィレブランド病を患う患者における消化管出血の治療
JP2021519280A (ja) 2018-03-21 2021-08-10 バクスアルタ インコーポレイテッド クロマトグラフィー法によるｖｗｆとｖｗｆプロペプチドの分離
EP4073105A1 (en) 2019-12-10 2022-10-19 Biotest AG Method for manufacturing a fibrinogen preparation

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4361509A (en) 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US5006642A (en) 1987-06-29 1991-04-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Purification of von Willebrand Factor by affinity chromatography
FR2632309B1 (fr) 1988-06-07 1990-08-24 Lille Transfusion Sanguine Procede de purification par voie chromatographique de proteines, notamment de facteur viii, et les produits obtenus
DE3904354A1 (de) 1989-02-14 1990-08-16 Behringwerke Ag Pasteurisiertes, gereinigtes von willebrand-faktor-konzentrat und verfahren zu seiner herstellung
FR2665449B1 (fr) * 1990-08-02 1995-04-14 Aquitaine Developp Transf Sang Procede de fabrication de facteur von willebrand ayant une tres haute purete, depourvu en majeure partie de facteur antihemophilique (fviiic), et facteur von willebrand ainsi obtenu, ainsi qu'une composition pharmaceutique le contenant.
NZ237244A (en) * 1990-03-02 1992-10-28 Bio Technology General Corp Cloning and production of human von willebrand factor analogues and compositions thereof
FR2673632A1 (fr) 1991-03-08 1992-09-11 Lille Transfusion Sanguine Procede de preparation de concentre de facteur von willebrand humain de tres haute purete, approprie a un usage therapeutique.
FR2686899B1 (fr) 1992-01-31 1995-09-01 Rhone Poulenc Rorer Sa Nouveaux polypeptides biologiquement actifs, leur preparation et compositions pharmaceutiques les contenant.
IT1256622B (it) 1992-12-04 1995-12-12 Sclavo Spa Processo per l'estrazione del complesso fattore viii-fattore von willebrand (fviii:c-fvw) da plasma umano totale.
CA2159044A1 (en) 1994-09-26 1996-03-27 Falko-Guenter Falkner Method of quantitating nucleic acids
AT401270B (de) 1994-09-26 1996-07-25 Immuno Ag Verfahren zur quantifizierung von genomischer dna
DE4435485C1 (de) 1994-10-04 1996-03-21 Immuno Ag Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor
DE4435392B4 (de) 1994-10-04 2008-02-07 Immuno Ag Verfahren zur Trennung von vWF in hochmolekularen vWF und niedermolekularen vWF
US5887152A (en) 1995-04-12 1999-03-23 Advanced Micro Devices, Inc. Load/store unit with multiple oldest outstanding instruction pointers for completing store and load/store miss instructions

Also Published As

Publication number Publication date
EP1005492B1 (de) 2007-04-11
DE59813967D1 (de) 2007-05-24
CA2282843C (en) 2008-12-02
AT405403B (de) 1999-08-25
ATA33797A (de) 1998-12-15
ATE359301T1 (de) 2007-05-15
WO1998038219A1 (de) 1998-09-03
AU5847098A (en) 1998-09-18
JP4250770B2 (ja) 2009-04-08
JP2001513088A (ja) 2001-08-28
NO324659B1 (no) 2007-11-26
EP1005492A1 (de) 2000-06-07
DK1005492T3 (da) 2007-08-13
US6465624B1 (en) 2002-10-15
AU737986B2 (en) 2001-09-06
CA2282843A1 (en) 1998-09-03
NO994138D0 (no) 1999-08-26
ES2285754T3 (es) 2007-11-16

Similar Documents

Publication Publication Date Title
NO994138D0 (no) Rensing av von Willebrand-faktor ved kationebytterkromatografi
CA2282841A1 (en) A method of purifying factor viii/vwf-complex by means of cation exchange chromatography
AU569129B2 (en) Factor viii:c purification
ATE76412T1 (de) Homogenes erythropoietin.
ATE73856T1 (de) Reinigung, herstellung und verwendung von tumor- nekrosisfaktoren.
DK1015587T3 (da) DcR3 polypeptid, en TNFR-homolog
HRP20020480B1 (en) Process for the purification of pharmacologically active proteins through cationic exchange chromatography
NO901769L (no) Fremgangsmaate for rensing av protein.
EA200200893A1 (ru) Очищенный лг
ATE278705T1 (de) Verfahren zur reinigung von proteinen
BRPI0417252A (pt) processo de purificação de beta interferon humano
DK0383645T3 (da) Fremgangsmåde til fremstilling af antihæmofilifaktor (FVIIIc) med meget høj renhed
ATE168097T1 (de) Verfahren zur reinigung von mittleren olefinen
DE69333141D1 (de) Verfahren zur reinigung einer rohen albuminwässerigen lösung
KR960014343A (ko) 활성형 인 과립구 콜로니 자극인자의 정제방법
DE69101425D1 (de) Methode zur Reinigung von rohem glycidyl (Meth)-Acrylat.
ATE82130T1 (de) Verfahren zum affinitaetschromatografischen reinigen von faktor xiii.
DK0408734T3 (da) Fremgangsmåde til rensning af streptokinaser
KR970006501A (ko) 재조합 효모로부터 과립구-콜로니자극인자(g-csf)를 정제하는 방법
RU1839190C (ru) Способ очистки микробной эстеразы
RU97110634A (ru) Способ получения рекомбинантного интерферона- гамма человека
BE902576A (fr) Traitement des immondices en récupérant la totalité
RO91266A2 (ro) Compozitie de cauciuc rezistenta la acid clorhidric concentrat
RU97118540A (ru) Средство для лечения дерматозов

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: BAXALTA INCORPORATED, CH

MK1K Patent expired